Both in Pharmaceuticals
Evolus vs Crescent Biopharma
Over the past year EOLS returned +15.3% and CBIO returned +5.7%; their daily moves had a correlation of 0.14.
EOLS +15.3% CBIO +5.7%Growth of $1, one year, split-adjusted
| Metric | EOLS | CBIO |
|---|---|---|
| Price | $7.37 | $13.06 |
| Market cap | $486.8M | $485.1M |
| Today | +2.93% | +1.16% |
| 1 month | −1.3% | −6.3% |
| 6 months | +15.7% | −27.8% |
| Year to date | +10.8% | +10.1% |
| 1 year | +14.1% | +2.4% |
| Revenue growth (YoY) | +21.2% | — |
| Gross margin | 68.0% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 40.8× |
| Net cash | -$141.9M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 52.8% | 68.9% |
| Short % of float | 12.2% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).